Product Information

BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB is a generic product labeled by Advagen Pharma Ltd., priced at $0.2128 per EA under NDC 72888022001. Its NADAC has been published 38 times since Feb 25, 2026.

FDA first approved this application on May 19, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB

benazepril hydrochloride and hydrochlorothiazide
$0.2128per EA

Strength

10; 12.5 mg/1; mg/1

NDC

72888022001

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Approval Type

Authorized Generic (NDA)

FDA Application

NDA020033

FDA Approved

5/19/1992

TE Code

AB

On Market Since

12/5/2024

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors
Decreased Blood Pressure
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has been published 38 times since Feb 25, 2026, and over the history we have for it it has declined 6.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2128 per EA
All-time high$0.2521 (Jul 15, 2026)
All-time low$0.2128 (Oct 21, 2026)
52-week high$0.2521
52-week low$0.2128
Median price$0.2282
Average price$0.2348
Largest weekly change+8.7% (May 20, 2026)
Weeks tracked38
Tracking sinceFeb 25, 2026

Price History

1W

0.0%

1M

-6.2%

3M

-15.4%

6M

-5.0%

1Y

N/A

3Y

N/A

5Y

N/A

All

-6.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the benazepril hydrochloride and hydrochlorothiazide market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB, manufactured by Advagen Pharma Ltd., is $0.2128 per EA (NDC 72888022001), effective Nov 11, 2026.

How has the price of BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has declined 6.7%. It has been tracked across 38 weekly CMS publications since Feb 25, 2026.

What are the highest and lowest recorded NADAC prices for BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?

Since Feb 25, 2026, the NADAC for BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has ranged from a low of $0.2128 (Oct 21, 2026) to a high of $0.2521 (Jul 15, 2026), with a median of $0.2282 per EA.

Are there cheaper alternatives to BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?

No other NADAC-published product currently shares the active ingredient and strength of BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?

BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB (NDC 72888022001) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.